Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · IEX Real-Time Price · USD
5.07
+0.17 (3.47%)
At close: Mar 28, 2024, 4:00 PM
5.17
+0.10 (1.97%)
After-hours: Mar 28, 2024, 7:09 PM EDT

BDTX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Selling, General & Admin
27.1128.3930.0421.367.581.950.67
Research & Development
59.3564.4496.8348.2121.756.953.45
Operating Expenses
86.4692.83126.8769.5729.338.94.12
Operating Income
-86.46-92.83-126.87-69.57-29.33-8.9-4.12
Interest Expense / Income
0000000.07
Other Expense / Income
-4.02-1.66-1.28-2.325.930.030.42
Pretax Income
-82.44-91.17-125.6-67.25-35.26-8.93-4.6
Net Income
-82.44-91.17-125.6-67.25-35.26-8.93-4.6
Shares Outstanding (Basic)
44363633222
Shares Outstanding (Diluted)
44363633222
Shares Change
21.00%0.38%9.97%1485.31%2.83%4.91%-
EPS (Basic)
-1.88-2.52-3.47-2.05-16.99-4.42-2.39
EPS (Diluted)
-1.88-2.52-3.47-2.05-16.99-4.42-2.39
Free Cash Flow
-66.66-85.27-102.86-52.29-24.7-8.53-2.43
Free Cash Flow Per Share
-1.52-2.35-2.84-1.59-11.90-4.23-1.26
EBITDA
-82.01-90.66-125.39-67.2-35.21-8.89-4.51
Depreciation & Amortization
0.440.510.210.050.050.040.02
EBIT
-82.44-91.17-125.6-67.25-35.26-8.93-4.54
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).